Fuller & Thaler Asset Management, Inc. Shockwave Medical, Inc. Transaction History

Fuller & Thaler Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$194.33 - $283.97 $15.4 Million - $22.4 Million	-79,039 Reduced 99.85%	116 $23,000
Q2 2023 Aug 14, 2023	BUY	$223.05 - $302.68 $1.44 Million - $1.95 Million	6,443 Added 8.86%	79,155 $22.6 Million
Q1 2023 May 15, 2023	BUY	$175.41 - $217.92 $882,663 - $1.1 Million	5,032 Added 7.43%	72,712 $15.8 Million
Q4 2022 Feb 13, 2023	SELL	$204.38 - $296.82 $36,379 - $52,833	-178 Reduced 0.26%	67,680 $13.9 Million
Q3 2022 Nov 14, 2022	BUY	$195.21 - $310.53 $4,685 - $7,452	24 Added 0.04%	67,858 $18.9 Million
Q2 2022 Aug 12, 2022	BUY	$115.91 - $214.48 $7.86 Million - $14.5 Million	67,834 New	67,834 $13 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.